REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 84,118 | $964,833 | 0.00% |
| Cape Investment Advisory, Inc. | 447 | $5,127 | 0.00% |
| Leucadia National | 30,394 | $348,619 | 0.00% |
| METROPOLITAN LIFE INSURANCE CO/NY | 4,832 | $55,423 | 0.00% |
| Qube Research & Technologies Ltd | 114,250 | $1,310,448 | 0.00% |
| DnB Asset Management AS | 23,946 | $274,661 | 0.00% |
| CarsonAllaria Wealth Management, Ltd. | 195 | $2,237 | 0.00% |
| DekaBank Deutsche Girozentrale | 86,100 | $1,012 | 0.00% |
| Swiss National Bank | 184,750 | $2,119,082 | 0.00% |
| CAPITAL FUND MANAGEMENT S.A. | 41,900 | $480,593 | 0.00% |
| Stephens Consulting, LLC | 500 | $5,735 | 0.00% |
| Arizona State Retirement System | 23,929 | $274,466 | 0.00% |
| CREDIT SUISSE AG/ | 140,615 | $1,612,854 | 0.00% |
| J.P. Morgan Private Wealth Advisors LLC | 54,329 | $623,154 | 0.00% |
| HRT FINANCIAL LP | 14,364 | $164 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 1,082,420 | $12,415,358 | 0.00% |
| SEI INVESTMENTS CO | 73,609 | $844,283 | 0.00% |
| FMR LLC | 1,894,107 | $21,725,407 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 1,780,277 | $20,422,402 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 142,302 | $1,632,204 | 0.00% |
External links
This page lists REVANCE THERAPEUTICS INC's shareholders in Q3 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.